Schizophrenia, psychosis, and the basal ganglia

Psychiatric Clinics of North America

Volumn 20, Issue 4, 1997, Pages 897-910

  Busatto, G F ^a   Kerwin, R W ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR;

AUTOPSY; BASAL GANGLION; BRAIN METABOLISM; CLINICAL FEATURE; CORPUS STRIATUM; DIAGNOSTIC IMAGING; HUMAN; MENTAL DISEASE; NEUROBIOLOGY; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA;

EID: 0031472785     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70351-8     Document Type: Article

References (83)

1. Akbarian S. Kim J.J. Potkin S.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics Arch Gen Psychiatry 52 1995 258
2. N.C. Andreasen S. Arndt V. Swayze Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging Science 266 1994 294
3. N.C. Andreasen K. Rezai R. Alliger Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia Arch Gen Psychiatry 49 1992 943
4. B. Angrist J. Rotrosen S. Gershon Differential effects of amphetamine and neuroleptics vs. positive symptoms in schizophrenia Psychopharmacology 72 1980 17
5. B. Bogerts E. Meertz R. Schonfeldt Bausch Basal ganglia and limbic system pathology in schizophrenia: A morphometric study of brain volume and shrinkage Arch Gen Psychiatry 42 1985 784
6. R. Brown N. Colter J.A. Corsellis Postmortem evidence of structural brain changes in schizophrenia: Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder Arch Gen Psychiatry 43 1986 36
7. G.F. Busatto A.S. David D.C. Costa Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography Psychiatric Research: Neuroimaging 61 1995 255
8. G.F. Busatto L.S. Pilowsky D.C. Costa Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia Am J Psychiatry 154 1997 56 63
9. M.S. Buchsbaum The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia Schizophr Bull 16 1990 379
10. M.S. Buchsbaum R.J. Haier S.G. Potkin Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics Arch Gen Psychiatry 49 1992 935
11. M.S. Buchsbaum J.C. Wu L.E. DeLisi Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with F-18-2-deoxyglucose in affective illness J Affect Disord 10 1986 137
12. M.P. Caligiuri J.B. Lohr D.V. Jeste Parkinsonism in neuroleptic-naive schizophrenic patients Am J Psychiatry 150 1993 1343
13. M. Carlsson A. Carlsson Schizophrenia: A subcortical neurotransmitter imbalance syndrome? Schizophr Bull 16 1990 425
14. M.F. Casanova K.A. Crapanzano G. Mannheim Sydenham's chorea and schizophrenia: A case report Schizophr Res 16 1995 73
15. M.H. Chakos J. Alvir M.G. Woerner Incidence and correlates of tardive dyskinesia in first episode of schizophrenia Arch Gen Psychiatry 53 1996 313
16. M.H. Chakos J.A. Lieberman J. Alvir Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine Lancet 345 1995 456
17. M.H. Chakos J.A. Lieberman R.M. Bilder Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs Am J Psychiatry 151 1994 1430
18. A. Chatterjee M. Chakos A. Koreen Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients Am J Psychiatry 152 1995 1724
19. L. Clare P.J. McKenna A.M. Mortimer Preserved procedural and implicit memory in schizophrenia—further evidence for an amnesic syndrome pattern of impairment Schizophr Res 6 1992 156
20. J.M. Cleghorn S. Franco B. Szechtman Toward a brain map of auditory hallucinations Am J Psychiatry 149 1992 1062
21. J.G. Csernansky G.M. Murphy W.O. Faustman Limbic/mesolimbic connections and the pathogenesis of schizophrenia Biol Psychiatry 30 1991 383
22. A. David A. Blamire H. Breiter Functional magnetic resonance imaging: A new technique with implications for psychology and psychiatry Br J Psychiatry 164 1994 2
23. K.L. Davis R.S. Kahn G. Ko Dopamine in schizophrenia: A review and reconceptualization Am J Psychiatry 148 1991 1474
24. A.Y. Deutch Identification of the neural systems subserving the actions of clozapine: Clues from immediate-early gene expression J Clin Psychiatry 55 9, suppl B 1994 37
25. Dolan R.J. Fletcher P. Frith C.D. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia Nature 378 1995 180
26. T.S. Early E.M. Reiman M.E. Raichle Left globus pallidus abnormality in never-medicated patients with schizophrenia Proc Natl Acad Sci USA 84 1987 561
27. 99mTc-exametazime in unmedicated schizophrenic patients Biol Psychiatry 33 1993 487
28. P. Falkai B. Bogerts Cytoarchitectonic and developmental studies in schizophrenia R.W. Kerwin Cambridge Medical Reviews: Neurobiology and Psychiatry vol 2 1993 Cambridge University Press Cambridge 43
29. 11C]raclopride Arch Gen Psychiatry 47 1990 213
30. W.S. Fenton R.J. Wyatt T.H. McGlashan Risk factors for spontaneous dyskinesia in schizophrenia Arch Gen Psychiatry 51 1994 643
31. 15O and positron emission tomography: Theory, procedure and normal values J Comput Assist Tomogr 4 1980 727
32. K.J. Friston Functional and effective connectivity in neuroimaging: A synthesis Human Brain Mapping 2 1994 56
33. C.D. Frith The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action Psychol Med 17 1987 631
34. C.D. Frith D.J. Donne Towards a neuropsychology of schizophrenia Br J Psychiatry 153 1988 437
35. T.E. Goldberg J.D. Ragland E.F. Torrey Neuropsychological assessment of monozygotic twins discordant for schizophrenia Arch Gen Psychiatry 47 1990 1066
36. J.A. Gray J. Feldon J.N.P. Rawlins The neuropsychology of schizophrenia Behavioral Brain Sciences 14 1991 1
37. 3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics Life Sci 40 1987 259
38. S. Heckers H. Heinsen Y. Heinsen Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study Biol Psychiatry 29 1991 556
39. H.H. Holcomb N.G. Cascella G.K. Thaker Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol Am J Psychiatry 153 1996 41
40. H. Jakob H. Beckmann Prenatal developmental disturbances in the limbic allocortex in schizophrenics J Neural Transm 65 1986 303
41. R.W. Kerwin How do the neuropathological changes of schizophrenia relate to pre-existing neurotransmitter and aetiological hypotheses? Psychol Med 19 1989 563
42. R.W. Kerwin The new atypical antipsychotics: A lack of extrapyramidal side-effects and new routes in schizophrenia research Br J Psychiatry 164 1994 141
43. 4 receptor in schizophrenia: An update Psychol Med 26 1996 221
44. M.S. Keshavan W.W. Bagwell G.L. Haas Changes in caudate volume with neuroleptic treatment Lancet 344 1994 1434
45. B.J. Klinon J.A. Lieberman Mechanisms of action of atypical antipsychotic drugs: A critical analysis Psychopharmacology 124 1996 2
46. Kraepelin E: Dementia Praecox and Paraphrenia. Edinburgh, Livingstone, 1913 (translated 1919 by RM Barclay)
47. P.F. Liddle K.J. Friston C.D. Frith Patterns of cerebral blood flow in schizophrenia Br J Psychiatry 160 1992 179
48. L. Marsh R.L. Suddath N. Higgins Medial temporal lobe structures in schizophrenia: Relationship of size to duration of illness Schizophr Res 11 1994 225
49. 2 receptors and negative symptoms of schizophrenia Br J Psychiatry 164 1994 27
50. 76Br-Bromolisuride Br J Psychiatry 158 1991 346
51. B. Mattsson Huntington's chorea in Sweden: II. Social and clinical data Acta Psychiatr Scand 255 suppl 1974 221
52. B. Meldrum GABA and acute psychoses Psychol Med 12 1982 1
53. A.M. Mortimer P.J. McKenna Levels of explanation—symptoms, neuropsychological deficit and morphological abnormalities in schizophrenia Psychol Med 24 1994 541
54. P. Murali Doraiswamy L.A. Tupler K. Ranga Rama Krishnan Neuroleptic treatment and caudate plasticity Lancet 345 1995 734
55. 31P-magnetic resonance spectroscopy Biol Psychiatry 29 1991 1149
56. B. Pakkenberg Post-mortem study of chronic schizophrenic brains Br J Psychiatry 151 1987 744
57. C. Pantelis T.R.E. Barnes H.E. Nelson Is the concept of frontal-subcortical dementia relevant to schizophrenia? Br J Psychiatry 160 1992 442
58. A. Parent L.-N. Hazrati Functional anatomy of the basal ganglia: I. The cortico-basal ganglia-thalamo-cortical loop Brain Res Rev 20 1995 91
59. 2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder Arch Gen Psychiatry 52 1995 471
60. B.M. Pedro L.S. Pilowsky D.C. Costa Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia Psychol Med 24 1994 423
61. 123I-IBZM single photon emission computerised tomography study Br J Psychiatry 164 1994 16
62. G.P. Reynolds Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia Acta Psychiatr Scand 89 suppl 380 1994 36
63. G.P. Reynolds Postmortem neurochemical studies in schizophrenia H. Haefner W.F. Gattaz W. Janzarik Search for the Causes of Schizophrenia 1987 Springer Heidelberg 236
64. G.S. Robertson H. Matsumura H.C. Fibiger Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity J Pharmacol Exp Ther 271 1994 1058
65. T.W. Robins The case for frontostriatal dysfunction in schizophrenia Schizophr Bull 16 1990 391
66. P. Rubin R. Hemmingsen S. Holm Relationship between brain structure and function in disorders of the schizophrenia spectrum: Single photon emission computed tomography, computed tomography and psychopathology of first episodes Acta Psychiatr Scand 90 1994 281
67. R. Sandyk S.P. Kay The relationship of negative schizophrenia to parkinsonism Int J Neurosci 55 1990 1
68. 4 receptors elevated in schizophrenia Nature 365 1993 441
69. P. Seeman T. Lee K. Chau-Wong Antipsychotic drug doses and neuroleptic/dopamine receptors Nature 261 1976 717
70. R.C. Shelton A.R. Doran D. Pickar Cerebral structural pathology in schizophrenia: Evidence for a selective prefrontal cortical deficit Am J Psychiatry 145 1988 154
71. B.V. Siegel Jr M.S. Buchsbaum W.E. Bunney Jr Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients Am J Psychiatry 150 1993 1325
72. D.A. Silbersweig E. Stern C. Frith A functional neuroanatomy of hallucinations in schizophrenia Nature 378 1995 176
73. 3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: Is selective loss of glutamatergic neurons associated with major psychoses? Neurochem Res 18 1993 219
74. J.R. Stevens An anatomy of schizophrenia? Arch Gen Psychiatry 29 1973 117
75. V.W. Swayze N.C. Andreasen R.J. Alliger Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study Biol Psychiatry 31 1992 221
76. N.R. Swerdlow Neuropsychology of schizophrenia: The “hole” thing is wrong (commentary on Gray JA et al: The neuropsychology of schizophrenia. Behavioral Brain Sciences 14:1, 1991) Behavioral Brain Sciences 14 1991 51
77. N.R. Swerdlow G.F. Koob Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function Behavioral Brain Sciences 10 1987 197
78. D.P. Van Kammen Gamma-aminobutyric acid (GABA) and the dopamine hypothesis of schizophrenia Am J Psychiatry 134 1977 138
79. 4 receptor with a high affinity for the antipsychotic clozapine Nature 350 1991 610
80. A. Vita S. Bressi D. Perani High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients Am J Psychiatry 152 1995 876
81. D.R. Weinberger B.K. Lipska Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground Schizophr Res 16 1995 87
82. 2 dopamine receptors in drug-naive schizophrenics Science 234 1986 1558
83. R.B. Zipursky K.O. Lim E.V. Sullivan Widespread cerebral gray matter volume deficits in schizophrenia Arch Gen Psychiatry 49 1992 195